September 5, 2024 Turing Medical’s Bullsai Identify Secures FDA Clearance: Ushering in A New Era of Precision Brain Mapping for Neuromodulation Therapy “Bullsai Identify’s personalized approach to brain mapping takes into account each patient’s unique brain structure and connectivity, offering the potential for better-targeted, more effective treatments, This can lead to more accurate therapies, […]
August 14, 2024 Turing Co-Founders Research on Psilocybin and Brain Plasticity Featured in Nature Psilocybin generates psychedelic experience by disrupting brain network Study advances efforts to harness drug’s mind-altering power to treat mental illness Tamara Schneider-Washington University in St. Louis People who consume psilocybin-containing mushrooms — […]
June 3, 2024 Turing Medical Launches New Brain Mapping and Targeting Solution at ASSFN Biannual Meeting Bullsai precision targeting for personalized neuromodulation therapy NASHVILLE, TENN., JUNE 1, 2024—Turing Medical, the leader in precision targeting for neuromodulation therapies, today announced the launch of Bullsai, its new brain mapping and […]
February 10, 2021 Turing Medical Co-Founder Damien Fair Awarded MacArthur Fellowship Fair among 21 winners of prestigious “Genius Grant”
February 10, 2021 Turing Medical Receives 510(k) Clearance from FDA for FIRMM Software Software provides real-time monitoring and biofeedback to improve MRI quality
April 26, 2020 Turing Medical Announces Ken Bruener Chief Executive Officer Long-time Medical Executive Steps in as Company Expands
December 2, 2019 Turing Medical Announces $6.6 Million in Funding for Brain MRI Software Solution Software designed to eliminate safety risks and billions of dollars in wasted costs